TEDMED | The promise and limits of cancer immunotherapy @TEDMED | Uploaded September 2018 | Updated October 2024, 6 hours ago.
Since its advent, there have been numerous conflicting reports about whether immunotherapy will be a “silver bullet” for different types of cancer, or if such expectations are based on hype or limited evidence. Many of the misconceptions about immunotherapy’s potential are due to our limited understanding of the immune system and how it serves to protect us from disease.
A pioneer in cancer care treatment, oncologist Lennie Sender has a deep understanding of both the possibilities and limitations of harnessing the immune system to treat different types of cancer. Check out Lennie’s 2017 TEDMED Talk for his straightforward report of the state of cancer immunotherapy options today and the promise they may hold for the future.
Since its advent, there have been numerous conflicting reports about whether immunotherapy will be a “silver bullet” for different types of cancer, or if such expectations are based on hype or limited evidence. Many of the misconceptions about immunotherapy’s potential are due to our limited understanding of the immune system and how it serves to protect us from disease.
A pioneer in cancer care treatment, oncologist Lennie Sender has a deep understanding of both the possibilities and limitations of harnessing the immune system to treat different types of cancer. Check out Lennie’s 2017 TEDMED Talk for his straightforward report of the state of cancer immunotherapy options today and the promise they may hold for the future.